TY - JOUR T1 - SARS-CoV-2 entry related genes are comparably expressed in children’s lung as adults JF - medRxiv DO - 10.1101/2020.05.25.20110890 SP - 2020.05.25.20110890 AU - Yue Tao AU - Ruwen Yang AU - Chen Wen AU - Jue Fan AU - Jing Ma AU - Qiao He AU - Zhiguang Zhao AU - Xinyu Song AU - Hao Chen AU - Guocheng Shi AU - Minzhi Yin AU - Nan Fang AU - Hao Zhang AU - Huiwen Chen AU - Xi Mo Y1 - 2020/01/01 UR - http://medrxiv.org/content/early/2020/05/26/2020.05.25.20110890.abstract N2 - To explore whether the expression levels of viral-entry associated genes might contribute to the milder symptoms in children, we analysed the expression of these genes in both children and adults’ lung tissues by single cell RNA sequencing (scRNA-seq) and immunohistochemistry (IHC). Both scRNA-seq and IHC analyses showed comparable expression of the key genes for SARS-CoV-2 entry in children and adults, including ACE2, TMPRSS2 and FURIN, suggesting that instead of lower virus intrusion rate, other factors are more likely to be the key reasons for the milder symptoms of SARS-CoV-2 infected children.Competing Interest StatementThe authors have declared no competing interest.Funding StatementNo external funding was received for this study.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:The study was approved by the Institutional Review Board and the Ethics Committee of Shanghai Children's Medical Center (SCMCIRB-K2020034), and written informed consent was obtained from (the parents of) each patient.All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesAll data can be found in the manuscript and the supplementary materials. ER -